Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Infusions for Resistant Major Depression
NCT02219867Unknown
- Sponsor
- Sheba Medical Center
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ketamine in major depressive disorder (MDD), sponsored by Sheba Medical Center. Primary endpoint: Montgomery Asberg Rating Scale at 24 hours. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02219867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219867.